MELA Sciences Inc. (MELA) announced Monday morning that it received an approvable letter from the FDA for MelaFind.
MELA Sciences Inc. gapped open sharply higher Monday, but traded in a range for the majority of the session. Shares finished up by 1.75 at $4.93 on strong volume. The stock broke out of a 3-week range and set a 10-month high.
For comments and feedback: editorial@rttnews.com